{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:05:48Z","timestamp":1789203948789,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,9,1]],"date-time":"2005-09-01T00:00:00Z","timestamp":1125532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2005,9]]},"DOI":"10.1016\/j.jaad.2005.06.011","type":"journal-article","created":{"date-parts":[[2005,8,19]],"date-time":"2005-08-19T07:34:22Z","timestamp":1124436862000},"page":"407-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":308,"title":["Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases"],"prefix":"10.1016","volume":"53","author":[{"given":"Timothy R.","family":"Cot\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna K.","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacquelyn A.","family":"Polder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc K.","family":"Walton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Miles","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2005.06.011_bib1","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S0140-6736(05)78793-6","article-title":"Botulinum toxin, a historical note","volume":"351","author":"Erbguth","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2005.06.011_bib2","first-page":"924","article-title":"Pharmacologic weakening of extraocular muscles","volume":"12","author":"Scott","year":"1973","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jaad.2005.06.011_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mds.870030409","article-title":"Systemic toxicity of botulinum toxin by intramuscular injection in the monkey","volume":"3","author":"Scott","year":"1988","journal-title":"Mov Disord"},{"key":"10.1016\/j.jaad.2005.06.011_bib4","first-page":"734","article-title":"Botulinum toxin injection of eye muscles to correct strabismus","volume":"79","author":"Scott","year":"1981","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.jaad.2005.06.011_bib5","unstructured":"PDR [package insert] (Allergan Botox). Available at: http:\/\/www.botox.com\/site\/professionals\/prescribing_info\/botox.asp. Accessed December 17, 2004"},{"key":"10.1016\/j.jaad.2005.06.011_bib6","unstructured":"PDR [package insert] (Allergan Botox Cosmetic). Available at: http:\/\/www.botox.com\/site\/professionals\/prescribing_info\/botox_cosmetic.asp. Accessed December 17, 2004."},{"key":"10.1016\/j.jaad.2005.06.011_bib7","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1053\/mda.2001.25136","article-title":"Other non-cosmetic uses of Botox","volume":"48","author":"Verheyden","year":"2002","journal-title":"Dis Mon"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.06.011_bib8","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1097\/00002508-200211001-00011","article-title":"Treatment of spasticity with botulinum toxin","volume":"18","author":"O'Brien","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jaad.2005.06.011_bib9","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1002\/(SICI)1097-4598(1997)6+<61::AID-MUS6>3.0.CO;2-H","article-title":"Traditional pharmacologic treatments for spasticity. Part I: local treatments. In Spasticity: etiology, evaluation, management and the role of botulinum toxin","volume":"6","author":"Gracies","year":"1997","journal-title":"Muscle Nerve Suppl"},{"key":"10.1016\/j.jaad.2005.06.011_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1046\/j.1440-1754.2003.00082.x","article-title":"Rehabilitation of spasticity and related problems in childhood cerebral palsy","volume":"39","author":"Flett","year":"2003","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/j.jaad.2005.06.011_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00128072-200305010-00002","article-title":"Spasticity associated with cerebral palsy in children: guidelines for the use of botulinum A toxin","volume":"5","author":"Koman","year":"2003","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.jaad.2005.06.011_bib12","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/00002060-200210000-00007","article-title":"Change of dynamic gastrocnemius and soleus muscle length after block of spastic calf muscle in cerebral palsy","volume":"81","author":"Bang","year":"2002","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.jaad.2005.06.011_bib13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/01.PHM.0000056989.67763.07","article-title":"Effect of botulinum toxin type A on cerebral palsy with upper limb spasticity","volume":"82","author":"Yang","year":"2003","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.jaad.2005.06.011_bib14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1469-8749.2002.tb00328.x","article-title":"Double-blind comparison study of two doses of botulinum toxin A injected into calf muscles in children with hemiplegic cerebral palsy","volume":"44","author":"Polak","year":"2002","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jaad.2005.06.011_bib15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1742-1241.2002.tb11324.x","article-title":"The role of botulinum toxin A in the management of lower limb spasticity in patients with cerebral palsy","volume":"56","author":"Dursun","year":"2002","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jaad.2005.06.011_bib16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-2002-34500","article-title":"Sonography-guided injection of botulinum toxin A in children with cerebral palsy","volume":"33","author":"Berweck","year":"2002","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.jaad.2005.06.011_bib17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1056\/NEJMoa011892","article-title":"Botox Post-Stroke Spasticitiy Study Group. Intramuscular injections of botulinum toxin for the treatment of wrist and finger spasticity after a stroke","volume":"347","author":"Brashear","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2005.06.011_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/apmr.2003.50077","article-title":"Disabling overactivity of the extensor hallicus longus after stroke: clinical expression and efficacy of botulinum toxin type A","volume":"84","author":"Yelnik","year":"2003","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.jaad.2005.06.011_bib19","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/00002060-200210000-00006","article-title":"Botulinum toxin type A use in piriformis muscle syndrome: a pilot study","volume":"81","author":"Childers","year":"2002","journal-title":"Am J Phys Med Rehabil"},{"key":"10.1016\/j.jaad.2005.06.011_bib20","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/00002060-200212000-00009","article-title":"Botox and physical therapy in the treatment of piriformis syndrome","volume":"81","author":"Fishman","year":"2002","journal-title":"Am J Phys Med Rehabil"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.06.011_bib21","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1097\/00002508-200211001-00009","article-title":"Use of botulinum toxins for chronic headaches: a focused review","volume":"18","author":"Loder","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jaad.2005.06.011_bib22","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1046\/j.1526-4610.2002.02234.x","article-title":"Relief of tension-type headache symptoms in subjects with temporomandibular disorders treated with botulinum toxin-A","volume":"42","author":"Freund","year":"2002","journal-title":"Headache"},{"key":"10.1016\/j.jaad.2005.06.011_bib23","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1046\/j.1468-2982.2002.00390.x","article-title":"Treatment of headache with botulinum toxin A\u2014a review according to evidence-based medicine criteria","volume":"22","author":"Rahmann Evers","year":"2002","journal-title":"Cephalalgia"},{"key":"10.1016\/j.jaad.2005.06.011_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11910-001-0016-8","article-title":"The treatment of tics","volume":"1","author":"Singer","year":"2001","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.jaad.2005.06.011_bib25","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1044\/1092-4388(2002\/067)","article-title":"Acoustic variations in reading produced by speakers with spasmodic dysphonia pre-Botox injection and within early stages of post-Botox injection","volume":"45","author":"Sapienza","year":"2002","journal-title":"J Speech Lang Hear Res"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.06.011_bib26","doi-asserted-by":"crossref","first-page":"S177","DOI":"10.1097\/00002508-200211001-00010","article-title":"A focused review on the use of botulinum toxins for neuropathic pain","volume":"18","author":"Argoff","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jaad.2005.06.011_bib27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1067\/mjd.2002.120455","article-title":"Botulinum toxin type A injection in the treatment of lichen simplex: an open pilot study","volume":"47","author":"Heckmann","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.06.011_bib28","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.1097\/00002508-200211001-00012","article-title":"Review of the use of botulinum toxin for hyperhidrosis and cosmetic purposes","volume":"18","author":"Glogau","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jaad.2005.06.011_bib29","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0149-2918(03)90041-5","article-title":"Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study","volume":"25","author":"Campanati","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2005.06.011_bib30","first-page":"167","article-title":"Botulinum toxin-A therapy for palmar and plantar hyperhidrosis","volume":"102","author":"Sevim","year":"2002","journal-title":"Acta Neurol Belg"},{"key":"10.1016\/j.jaad.2005.06.011_bib31","first-page":"181","article-title":"Intracutaneous botulinum toxin A versus ablative therapy of Hailey-Hailey disease\u2014a case report","volume":"3","author":"Konrad","year":"2001","journal-title":"J Cosmet Laser Ther"},{"key":"10.1016\/j.jaad.2005.06.011_bib32","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1468-3083.2002.00361.x","article-title":"Adjuvant botulinum toxin A in dyshidrotic hand eczema: a controlled prospective pilot study with left-right comparison","volume":"16","author":"Wollina","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2005.06.011_bib33","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1055\/s-2002-33225","article-title":"Long-term results and prognostic factors in the treatment of achalasia with botulinum toxin","volume":"34","author":"Neubrand","year":"2002","journal-title":"Endoscopy"},{"key":"10.1016\/j.jaad.2005.06.011_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1442-2050.2003.00287.x","article-title":"Intrasphincteric botulinum toxin injection in the treatment of chagasic achalasia","volume":"16","author":"Brant","year":"2003","journal-title":"Dis Esophagus"},{"key":"10.1016\/j.jaad.2005.06.011_bib35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00004836-200303000-00005","article-title":"Intrasphincteric botulinum toxin verses pneumatic balloon dilation for treatment of primary achalasia","volume":"36","author":"Bansal","year":"2003","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jaad.2005.06.011_bib36","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/jama.288.4.439-JMN0724-3-1","article-title":"Colon and rectal surgeons are trying Botox treatment, too","volume":"288","author":"Mitka","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2005.06.011_bib37","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s10350-004-6528-y","article-title":"Comparison of botulinum toxin injection and lateral internal sphincterotomy for the treatment of chronic anal fissure","volume":"46","author":"Mentes","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.jaad.2005.06.011_bib38","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/00042737-200208000-00007","article-title":"Side effects of botulinum toxin injection for benign anal disorders","volume":"14","author":"Madalinski","year":"2002","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jaad.2005.06.011_bib39","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10350-004-7296-4","article-title":"Safety of botulinum neurotoxin treatment in patients with chronic anal fissure","volume":"46","author":"Brisinda","year":"2003","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.jaad.2005.06.011_bib40","first-page":"660","article-title":"Botulinum toxin type A (Dysport) for the treatment of Zenker's diverticulum","volume":"17","author":"Spinelli","year":"2003","journal-title":"Surg Endosc"},{"key":"10.1016\/j.jaad.2005.06.011_bib41","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s10286-002-0026-x","article-title":"The role of gustatory flushing in Frey's syndrome and its treatment with botulinum toxin type A","volume":"12","author":"Tugnoli","year":"2002","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.jaad.2005.06.011_bib42","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1054\/bjom.2000.0608","article-title":"Botulinum toxin in the treatment of Frey's syndrome","volume":"39","author":"Clark","year":"2001","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.jaad.2005.06.011_bib43","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1055\/s-2002-37084","article-title":"Successful management of drooling with botulinum toxin A in neurologically disabled children","volume":"33","author":"Ellies","year":"2002","journal-title":"Neuropediatrics"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.06.011_bib44","first-page":"23","article-title":"Botulinum toxin for treatment of parkinsonian sialorrhea","volume":"35","author":"Friedman","year":"2001","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.jaad.2005.06.011_bib45","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1097\/00006534-200206000-00041","article-title":"New prospects in the treatment of traumatic and postoperative parotid fistulas with type A botulinum toxin","volume":"109","author":"von Lindern","year":"2002","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jaad.2005.06.011_bib46","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s001920200013","article-title":"Botulinum toxin uretheral sphincter injection resolves urinary retention after pubovaginal sling operation","volume":"13","author":"Smith","year":"2002","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"10.1016\/j.jaad.2005.06.011_bib47","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0090-4295(01)01641-7","article-title":"Efficacy of botulinum-A toxin in children with detrusor hyperreflexia due to myelomeningocele: preliminary results","volume":"59","author":"Schulte-Baukloh","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.jaad.2005.06.011_bib48","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/sj.eye.6700230","article-title":"Treatment of gustatory hyperlacrimation (crocodile tears) with injection of botulinum toxin into the lacrimal gland","volume":"16","author":"Montoya","year":"2002","journal-title":"Eye"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.06.011_bib49","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1097\/00002508-200211001-00013","article-title":"Treatment of temporomandibular disorders with botulinum toxin","volume":"18","author":"Schwartz","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jaad.2005.06.011_bib50","doi-asserted-by":"crossref","first-page":"359","DOI":"10.7326\/0003-4819-138-4-200302180-00026","article-title":"Antral injections of botulinum A toxin for the treatment of obesity","volume":"138","author":"Rollnik","year":"2003","journal-title":"Ann Intern Med"},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.06.011_bib51","doi-asserted-by":"crossref","first-page":"S155","DOI":"10.1097\/00002508-200211001-00007","article-title":"A focused review of the use of botulinum toxins for low back pain","volume":"18","author":"Difazio","year":"2002","journal-title":"Clin J Pain"},{"key":"10.1016\/j.jaad.2005.06.011_bib52","first-page":"393","article-title":"Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experience","volume":"9","author":"Kocs","year":"2003","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.jaad.2005.06.011_bib53","first-page":"425","article-title":"Off-label applications for SSRIs","volume":"68","author":"Stone","year":"2003","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.jaad.2005.06.011_bib54","first-page":"9","article-title":"Off-label use of tumor necrosis factor inhibitors on ankylosing spondylitis, ulcerative colitis, and psoriasis","volume":"20","year":"2003","journal-title":"TEC Bull"},{"key":"10.1016\/j.jaad.2005.06.011_bib55","unstructured":"American Society of Plastic Surgeons. Available at http:\/\/www.plasticsurgery.org\/public_education\/procedures\/Botox.cfm. Accessed December 17, 2004."},{"key":"10.1016\/j.jaad.2005.06.011_bib56","unstructured":"American Society for Dermatologic Surgery. Available at http:\/\/www.asds-net.org\/Patients\/patients-procedures.html. Accessed December 17, 2004."},{"key":"10.1016\/j.jaad.2005.06.011_bib57","unstructured":"American Society of Aesthetic Plastic Surgery. Available at http:\/\/www.surgery.org\/public\/procedures-botoxing.php. Accessed December 17, 2004."},{"issue":"Suppl","key":"10.1016\/j.jaad.2005.06.011_bib58","first-page":"S135","article-title":"Adverse events reported with cosmetic use of botulinum toxin A","volume":"10","author":"Gershon","year":"2001","journal-title":"Pharmacoepidemiology Drug Safety"},{"key":"10.1016\/j.jaad.2005.06.011_bib59","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1001\/jama.281.9.824","article-title":"Postmarketing surveillance and adverse drug reactions: current perspectives and future needs","volume":"281","author":"Brewer","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2005.06.011_bib60","series-title":"Pharmacoepidemiology","first-page":"151","article-title":"Spontaneous reporting in the United States","author":"Kennedy","year":"2000"},{"key":"10.1016\/j.jaad.2005.06.011_bib61","series-title":"Pharmacoepidemiology","first-page":"125","article-title":"The spontaneous reporting system in the United States","author":"Baum","year":"1994"},{"key":"10.1016\/j.jaad.2005.06.011_bib62","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archpedi.1997.02170400041007","article-title":"Syncope after immunization","volume":"151","author":"Braun","year":"1997","journal-title":"Arch Pediatr Adolesc Med"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205019857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962205019857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T21:39:18Z","timestamp":1759268358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962205019857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,9]]},"references-count":62,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,9]]}},"alternative-id":["S0190962205019857"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2005.06.011","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2005,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum toxin type A injections: Adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2005.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}